Obstructive urination problems after high-dose-rate brachytherapy boost treatment for prostate cancer are avoidable
References
- Mottet N, Bastian PJ, Bellmunt J, Van den Bergh RCN, Bolla M, Van Casteren NJ, et al. Guidelines on prostate cancer. Arnhem: European Association of Urology; 2014.
- Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, et al. Comparative analysis of prostate specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 2012; (109 Suppl 1): 22-9.
- Hoskin PJ, Rojas AM, Bownes PJ, Lowe GJ, Ostler PJ, Bryant L. Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. Radiother Oncol 2012; 103: 217-22.
- Khor R, Duchesne G, Tai KH, Foroudi F, Chander S, Van Dyk S, et al. Direct 2-arm comparison shows benefit of high-dose-rate brachytherapy boost vs external beam radiation therapy alone for prostate cancer. Int J Radiat Biol Phys 2012; 85: 679-85.
- Pieters BR, de Back DZ, Koning CC, Zwinderman AH. Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review. Radiother Oncol 2009; 93: 168-173.
- Lepor H. Prevention and management of complications associated with open radical retropubic prostatectomy. In: Kirby RS, Partin AW, Feneley M, Parsons JK, editors. Prostate cancer principles and practice. London: Taylor & Francis; 2006 p. 789-97.
- Cesaretti JA, Stone NN, Kao J. Brachytherapy for the treatment of prostate cancer. In: Kirby RS, Partin AW, Feneley M, Parsons JK, editors. Prostate cancer principles and practice. London: Taylor & Francis; 2006. p. 817-29.
- Elliott SP, Meng MV, Elkin EP, McAninch JW, Duchane J, Carroll PR, CaPSURE Investigators. Incidence of urethral stricture after primary treatment for prostate cancer. J Urol 2007; 178: 529-34.
- Deger S, Boehmer D, Roigas J, Schink T, Wernecke KD, Wiegel T, et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. Eur Urol 2005; 47: 441-8.
- Vargas CE, Martinez AA, Boike TP, Spencer W, Goldstein N, Gustafson GS, et al. High-dose irradiation for prostate cancer via a high-dose-rate brachy-therapy boost: results of a phase I to II study. Int J Radiat Biol Phys 2006; 66: 416-23.
- Yamada Y, Bhatia S, Zaider M, Cohen G, Donat M, Eastham J, et al. Favorable clinical outcomes of three dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 2006; 5: 157-64.
- Demanes DJ, Rodriguez RR, Schour L, Brandt D, Altieri G. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy’s 10-year results. Int J Radiat Biol Phys 2005; 61: 1306-16.
- Hindson BR, Millar JL, Matheson B. Urethral strictures following high-dose-rate brachytherapy for prostate cancer: analysis of risk factors. Brachytherapy 2013; 12: 50-5.
- Martínez-Monge R, Moreno M, Ciérvide R, Cambeiro M, Pérez-Gracia JL, Gil-Bazo I, et al. External-beam radiation therapy and high-dose-rate brachy-therapy combined with long-term androgen deprivation therapy in high and very high prostate cancer: preliminary data on clinical outcome. Int J Radiat Biol Phys 2012; 82: 469-76.
- Sullivan L, Williams SG, Tai KH, Foroudi F, Cleeve L, Duchesne GM. Urethral stricture following high dose rate brachytherapy for prostate cancer. Radiother Oncol 2009; 91: 232-6.
- Galalae RM, Kovács G, Schultze J, Loch T, Rzehak P, Wilhelm R, et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Biol Phys 2002; 52: 81-90.
- Yamada Y, Rogers L, Demanes DJ, Morton G, Prestidge BR, Pouliot J, et al. American brachytherapy society consensus guidlines for high-dose-rate prostate brachytherapy. Brachytheapy 2012; 11: 20-32.
- Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Allen ZA, et al. Risk factors for the development of prostate brachytherapy related urethral strictures. J Urol 2006; 175: 1376-81.
- Parihar JS, Ha YS, Kim IY. Bladder neck contracture-incidence and management following contemporary robot assisted radical prostatectomy. Prostate Int 2014; 1: 12-8.
- Breyer BN, Davis CB, Cowan JE, Kane CJ, Carroll PR. Incidence of bladder neck contracture after robot-assisted laparoscopic and open radical prostatectomy. BJU Int 2010; 106: 1734-8.
- D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74.
- Grabec D, Kragelj B. The sigmoid colon and bladder shielding in whole pelvic irradiation at prostate cancer (forward planned IMRT from Institute of oncology Ljubljana). Radiol Oncol 2009; 43: 56-64.
- Roach M 3rd, Marquez C, Yuo HS, Narayan P, Coleman L, Nseyo UO, et al. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1994; 28: 33-7.
- Cox JD, Stetz JA, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Biol Phys 1995; 31: 1341-6.
- Marks LB, Carroll PR, Dugan TC, Anscher MS. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Biol Phys 1995; 31: 1257-80.
- Hosmer DW, Lemeshow S. Applied logistic regression. New York (NY): John Wiley & Sons; 2000.
- McNeil BJ, Keeler E, Adelstein JS. Primer on certain elements of medical decision making. N Engl J Med 1975; 293: 211-215.
- Bradley GW, editor. Disease, diagnosis and decisions. Chichester: John Wiley & Sons; 1993.
- Kallin Westin L. Receiver operating characteristic (ROC) analysis: valuating discriminance effects among decision support systems. Umea: Umea University, Department of Computing Science; 2001.
- Schisterman EF, Perkins NJ, Liu A, Bondell H. Optimal cut-point and corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology 2005; 16: 73-81.
- Mathieu R, Arango JD, Beckendorf V, Delobel JB, Messai T, Chira C, et al. Nomograms to predict late urinary toxicity after prostate cancer radiotherapy. World J Urol 2014; 32: 743-51.
- Hsu IC, Hunt D, Straube W, Pouliot J, Cunha A, Krishnamurthy D, et al. Dosimetric analysis of radiation therapy oncology group 0321: The importance of urethral dose. Pract Radiat Oncol 2014; 4: 27-34.
- McLaughlin PW, Narayana V. High-dose-rate strictures: A theory of cancer meets anatomic reality. Brachytherapy 2013; 12: 199-201.
- Ishiyama H, Kitano M, Satoh T, Kotani S, Uemae M, Matsumoto K, et al. Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity. Int J Radiat Biol Phys 2009; 75: 23-8.
- Ghadjar P, Rentsch CA, Isaak B, Behrensmeier F, Thalmann GN, Aebersold DM. Urethral toxicity vs. cancer control – lessons to be learned from high-dose rate brachytherapy combined with intensity-modulated radiation therapy in intermediate-and high-risk prostate cancer. Brachytherapy 2011; 11: 286-94.
- Pellizzon ACA, Salvajoli JV, Maia MAC, Ferrigno R, Dos Santos Novaes PER, Fogarolli RC, et al. Late urinary morbidity with high dose prostate brachy-therapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer. J Urol 2004; 171: 1105-8.
- Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Eble MJ. Low-grade toxicity after conformal radiation therapy for prostate cancer-impact of bladder volume. Int J Radiat Biol Phys 2006; 64: 835-41.
- Ali AN, Rossi PJ, Godette KD, Martin D, Liauw S, Vijayakumar S, et al. Impact of magnetic resonance imaging on computed tomography –based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy. Pract Radiat Oncol 2013; 3: e1-9.
Language: English
Page range: 94 - 103
Submitted on: Oct 15, 2014
Accepted on: Jan 20, 2015
Published on: Feb 16, 2016
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2016 Borut Kragelj, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.